Breaking News Instant updates and real-time market news.

BBU

Brookfield Business Partners

$38.83

(0.00%)

, EYE

National Vision

$33.18

0.01 (0.03%)

08:30
04/13/18
04/13
08:30
04/13/18
08:30

Thirteen new option listings and ten option delistings on April 13th

New option listings for April 13th include iPath Bloomberg Cotton Subindex Total Return ETN (BALTF), Brookfield Business Partners (BBU), iPath Bloomberg Livestock Subindex Total Return ETN (COWTF), NTT DOCOMO Inc (ADR) (DCMYY), National Vision Holdings Inc (EYE), Innovate Biopharmaceuticals Inc (INNT), iPath MCSI India Index ETN (INPTF), iPath Bloomberg Copper Subindex Total Return ETN (JJCTF), iPath Bloomberg Grains Subindex Total Return ETN (JJGTF), iPath Bloomberg Coffee Subindex Total Return ETN (JJOFF), iPath S&P GSCI Crude Oil Total Return (OILNF), iPath Bloomberg Sugar Subindex Total Return ETN (SGGFF), and Tandem Diabetes (TNDM). Option delistings effective April 13th include iPath Bloomberg Cotton Subindex Total Return ETN (BAL), iPath Bloomberg Livestock Subindex Total Return ETN (COW), NTT DOCOMO Inc (ADS) (DCM), iPath MCSI India Index ETN (INP), iPath Bloomberg Copper Subindex Total Return ETN (JJC), iPath Bloomberg Grains Subindex Total Return ETN (JJG), iPath Bloomberg Coffee Subindex Total Return ETN (JO), iPath S&P GSCI Crude Oil Total Return (OIL), Ply Gem Holdings Inc (PGEM), and iPath Bloomberg Sugar Subindex Total Return ETN (SGG).

BBU

Brookfield Business Partners

$38.83

(0.00%)

EYE

National Vision

$33.18

0.01 (0.03%)

INNT

Innovate Biopharmaceuticals

$27.96

3.35 (13.61%)

TNDM

TNDM

BAL

Balanced Care

$0.00

(0.00%)

DCM

NTT DoCoMo

$0.00

(0.00%)

OIL

Triton Energy

$0.00

(0.00%)

PGEM

Taken private

$21.65

(0.00%)

SGG

iPath Dow Jones-UBS Sugar Subindex

$0.00

(0.00%)

  • 26

    Apr

  • 07

    May

  • 08

    May

BBU Brookfield Business Partners
$38.83

(0.00%)

01/18/18
01/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Caterpillar (CAT) initiated with a Buy at Berenberg. 2. Rosehill Resources (ROSE) initiated with an Outperform at Northland. 3. Arena Pharmaceuticals (ARNA) initiated with an Outperform at Credit Suisse. 4. Electronic Arts (EA) was initiated with an Outperform at Bernstein, while Activision Blizzard (ATVI) was initiated with a Market Perform. 5. Brookfield Business Partners (BBU) initiated with a Sector Perform at RBC Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/18/18
RBCM
01/18/18
INITIATION
Target $41
RBCM
Sector Perform
Brookfield Business Partners initiated with a Sector Perform at RBC Capital
RBC Capital analyst Geoffrey Kwan initiated Brookfield Business Partners with a Sector Perform rating and a price target of $41. Kwan says the company offers a "strong investment track record and a diverse collection of investments in the Business Services, Industrials, Energy and Construction sectors". The analyst also sees units as fairly valued over the 12-month horizon, trading at a slight premium relative to his estimated NAV.
01/05/18
FBCO
01/05/18
NO CHANGE
Target $42
FBCO
Outperform
Brookfield Business Partners price target raised to $42 from $34 at Credit Suisse
Credit Suisse analyst Nick Stogdill noted that Brookfield Business Partners (BBU) and its institutional partners will acquire 100% of Westinghouse Electric from Toshiba (TOSBF) for $4.6B, which he views as positive news from both a strategic and financial perspective. The analyst, who increased his 2018 EPS estimate 11% to $3.15 to reflect the deal, keeps an Outperform rating on Brookfield Business Partners and raised his price target on the stock to $42.
03/16/18
RBCM
03/16/18
UPGRADE
RBCM
Outperform
Brookfield Business upgraded to Outperform from Sector Perform at RBC Capital
EYE National Vision
$33.18

0.01 (0.03%)

11/21/17
GUGG
11/21/17
INITIATION
GUGG
Buy
National Vision initiated with a Buy at Guggenheim
11/20/17
11/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Innoviva (INVA) initiated with a Hold at Deutsche Bank. 2. National Vision (EYE) was initiated with an Overweight at Morgan Stanley, an Outperform at Wells Fargo, a Buy at Jefferies and Citi, as well as a Neutral at Goldman Sachs, UBS, and BofA/Merrill. 3. Ablynx (ABLX) was initiated with an Overweight at JPMorgan, an Outperform at Baird, and a Buy at Ladenburg. 4. Blue Apron (APRN) initiated with a Sector Weight at KeyBanc. 5. BP Midstream (BPMP) was initiated with an Overweight at JPMorgan, a Buy at UBS and Citi, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/20/17
GSCO
11/20/17
INITIATION
Target $30
GSCO
Neutral
National Vision initiated with a Neutral at Goldman Sachs
Goldman analyst Matthew Fassler initiated National Vision with a Neutral and $30 price target saying valuation reflects the company's appealing growth profile.
01/18/18
WELS
01/18/18
NO CHANGE
Target $45
WELS
Outperform
National Vision price target raised to $45 from $37 at Wells Fargo
Wells Fargo analyst Zachary Fadem raised his price target for National Vision to $45 from $37 to reflect tax reform. The analyst reiterates an Outperform rating on the shares.
INNT Innovate Biopharmaceuticals
$27.96

3.35 (13.61%)

TNDM TNDM

04/10/18
PIPR
04/10/18
NO CHANGE
PIPR
Neutral
Too early to call Tandem Diabetes revenue beat a trend, says Piper Jaffray
Piper Jaffray analyst JP McKim noted that Tandem Diabetes announced preliminary Q1 revenue that beat his estimate of $24.8M and the consensus view near $25M. McKim, who thinks the company "clearly benefited" from the exit of Animas from the U.S. market, is incrementally more positive on Tandem but awaits more evidence of an accelerating growth trend before changing his Neutral rating on the stock.
03/23/18
03/23/18
UPGRADE
Target $7

Outperform
Tandem Diabetes upgraded to Outperform at Baird
As previously reported, Baird upgraded Tandem Diabetes to Outperform from Neutral and raised its price target to $7 from $3. Analyst Jeff Johnson has gone from thinking that Tandem may not survive to believing management may have the most compelling HCL system in diabetes by mid-2019. Johnson's newfound conviction in the product pipeline comes from management's prudent move of its t:slim X2 Insulin Pump system to a PMA versus 510(k) platform two years ago, that helped establish important relationships with FDA's PMA division. Further, the analyst believes Tandem's timeline for potential approval of its Control IQ system in 1H19 looks more reasonable than we previously realized, leading to a potential launch by mid-2019, and a head start over Medtronic's (MDT) 670G system and Insulet's (PODD) advanced HCL system.
03/28/18
COWN
03/28/18
UPGRADE
Target $7
COWN
Outperform
Tandem Diabetes upgraded to Outperform from Market Perform at Cowen
Cowen analyst Doug Schenkel upgraded Tandem Diabetes to Outperform and raised his price target for the shares to $7 from $5.
03/28/18
COWN
03/28/18
UPGRADE
Target $7
COWN
Outperform
Tandem Diabetes upgraded to Outperform on market share gains at Cowen
As reported previously, Cowen analyst Doug Schenkel upgraded Tandem Diabetes (TNDM) to Outperform from Market Perform. The analyst cited his recent diabetes devices survey, which suggested the company is picking up market share from Animas' market exit and he sees excitement about its integration with Dexcom (DXCM). Schenkel raised his price target to $7 from $5 on Tandem Diabetes shares.
BAL Balanced Care
$0.00

(0.00%)

DCM NTT DoCoMo
$0.00

(0.00%)

12/14/17
DBAB
12/14/17
DOWNGRADE
DBAB
Sell
NTT DoCoMo downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank downgraded NTT DoCoMo to Sell with a price target of 2,550 yen.
01/21/18
HSBC
01/21/18
DOWNGRADE
HSBC
Hold
NTT DoCoMo downgraded to Hold from Buy at HSBC
01/26/18
DBAB
01/26/18
UPGRADE
DBAB
Hold
NTT DoCoMo upgraded to Hold from Sell at Deutsche Bank
04/11/18
UBSW
04/11/18
INITIATION
UBSW
Sell
NTT DoCoMo initiated with a Sell at UBS
UBS analyst Kei Takahashi started NTT DoCoMo with a Sell rating.
OIL Triton Energy
$0.00

(0.00%)

PGEM Taken private
$21.65

(0.00%)

02/21/18
RBCM
02/21/18
DOWNGRADE
RBCM
Sector Perform
Ply Gem downgraded to Sector Perform from Outperform at RBC Capital
Ply Gem (PGEM) is being acquired by Clayton, Dubilier & Rice for $21.64 per share in cash.
SGG iPath Dow Jones-UBS Sugar Subindex
$0.00

(0.00%)

TODAY'S FREE FLY STORIES

IRBT

iRobot

$93.11

2.25 (2.48%)

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Upgrade
iRobot rating change  »

iRobot upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

10:25
10/16/18
10/16
10:25
10/16/18
10:25
Conference/Events
Morgan Stanley to hold an analyst/industry conference call »

Vice President Kaufman…

ABT

Abbott

$69.86

1.14 (1.66%)

, BSX

Boston Scientific

$37.64

1.21 (3.32%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

ABT

Abbott

$69.86

1.14 (1.66%)

BSX

Boston Scientific

$37.64

1.21 (3.32%)

SYK

Stryker

$172.45

3.03 (1.79%)

MDT

Medtronic

$95.39

1.58 (1.68%)

BAX

Baxter

$71.00

0.12 (0.17%)

EW

Edwards Lifesciences

$144.31

2.36 (1.66%)

ZBH

Zimmer Biomet

$124.31

0.72 (0.58%)

EXPE

Expedia

$120.28

1.73 (1.46%)

TRIP

TripAdvisor

$46.17

1.17 (2.60%)

BKNG

Booking Holdings

$1,824.49

12.59 (0.69%)

FB

Facebook

$156.16

2.6 (1.69%)

SNAP

Snap

$7.23

-0.18 (-2.43%)

VFC

VF Corp.

$88.01

0.36 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 05

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 15

    Nov

PF

Pinnacle Foods

$66.43

0.2 (0.30%)

, AMRX

Amneal Pharmaceuticals

$18.05

-0.68 (-3.63%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

PF

Pinnacle Foods

$66.43

0.2 (0.30%)

AMRX

Amneal Pharmaceuticals

$18.05

-0.68 (-3.63%)

SCCO

Southern Copper

$41.72

-0.42 (-1.00%)

SNN

Smith & Nephew

$34.42

0.28 (0.82%)

SPRO

Spero Therapeutics

$8.19

-1.64 (-16.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 07

    Nov

  • 28

    Feb

SYMC

Symantec

$19.92

0.14 (0.71%)

, LVS

Las Vegas Sands

$56.55

0.71 (1.27%)

10:23
10/16/18
10/16
10:23
10/16/18
10:23
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

SYMC

Symantec

$19.92

0.14 (0.71%)

LVS

Las Vegas Sands

$56.55

0.71 (1.27%)

CGNX

Cognex

$46.21

2.11 (4.78%)

TPR

Tapestry

$43.55

0.46 (1.07%)

CBRL

Cracker Barrel

$156.00

2.86 (1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 19

    Nov

  • 06

    Dec

JNJ

Johnson & Johnson

$137.42

3.67 (2.74%)

, SYK

Stryker

$172.58

3.16 (1.87%)

10:22
10/16/18
10/16
10:22
10/16/18
10:22
Recommendations
Johnson & Johnson, Stryker, Zimmer Biomet, Globus Medical, NuVasive, SeaSpine, Cooper Companies, Insulet, TNDM analyst commentary  »

Piper Jaffray discusses…

JNJ

Johnson & Johnson

$137.42

3.67 (2.74%)

SYK

Stryker

$172.58

3.16 (1.87%)

ZBH

Zimmer Biomet

$124.31

0.72 (0.58%)

GMED

Globus Medical

$52.54

0.57 (1.10%)

NUVA

NuVasive

$66.97

1.36 (2.07%)

SPNE

SeaSpine

$15.96

-0.03 (-0.19%)

COO

Cooper Companies

$254.67

1.63 (0.64%)

PODD

Insulet

$90.55

1.64 (1.84%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 27

    Nov

TVTY

Tivity Health

$32.62

0.39 (1.21%)

10:22
10/16/18
10/16
10:22
10/16/18
10:22
Hot Stocks
Tivity says SilverSneakers coming to North Carolina, California MA members »

Tivity Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 27

    Nov

QCOM

Qualcomm

$65.29

1.11 (1.73%)

10:20
10/16/18
10/16
10:20
10/16/18
10:20
Options
Aggressive call buying in Qualcomm »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

10:20
10/16/18
10/16
10:20
10/16/18
10:20
General news
U.S. JOLTS report showed job openings rose 59k to 7,136k in August »

U.S. JOLTS report showed…

10:20
10/16/18
10/16
10:20
10/16/18
10:20
General news
Treasury Action: yields rebounded from lows »

Treasury Action: yields…

TROX

Tronox

$11.91

0.05 (0.42%)

10:20
10/16/18
10/16
10:20
10/16/18
10:20
Conference/Events
UBS basic materials analyst to hold an analyst/industry conference call »

Analyst Roberts discuss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 06

    Nov

GS

Goldman Sachs

$218.11

2.83 (1.31%)

10:19
10/16/18
10/16
10:19
10/16/18
10:19
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman expects to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

TVTY

Tivity Health

$32.62

0.39 (1.21%)

10:19
10/16/18
10/16
10:19
10/16/18
10:19
Hot Stocks
Tivity says SilverSneakers available to Ohio MA members in 2019 »

Tivity Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 27

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/16/18
10/16
10:17
10/16/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/16/18
10/16
10:16
10/16/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$276.93

2.31 (0.84%)

, SPX

S&P 500

$0.00

(0.00%)

10:14
10/16/18
10/16
10:14
10/16/18
10:14
General news
Trump says 'it's all working,' citing 'incredible' job openings data »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$276.93

2.31 (0.84%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$32.62

0.39 (1.21%)

10:13
10/16/18
10/16
10:13
10/16/18
10:13
Hot Stocks
Tivity says SilverSneakers available to Wisconsin MA members in 2019 »

Tivity Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 27

    Nov

MU

Micron

$42.81

0.47 (1.11%)

10:10
10/16/18
10/16
10:10
10/16/18
10:10
Options
Flurry of activity in Micron Tech call options Tuesday morning »

Flurry of activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
10/16/18
10/16
10:10
10/16/18
10:10
General news
U.S. NAHB housing market index rose 1 point to 68 in October »

U.S. NAHB housing market…

MS

Morgan Stanley

$44.50

1.05 (2.42%)

10:09
10/16/18
10/16
10:09
10/16/18
10:09
Upgrade
Morgan Stanley rating change  »

Morgan Stanley upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

ALBO

Albireo Pharma

$27.08

-0.88 (-3.15%)

10:03
10/16/18
10/16
10:03
10/16/18
10:03
Hot Stocks
Albireo Pharma treatment of Alagille syndrome granted orphan status »

The FDA granted orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CORT

Corcept Therapeutics

$12.74

0.21 (1.68%)

10:03
10/16/18
10/16
10:03
10/16/18
10:03
Hot Stocks
Corcept granted orphan status for Cushing syndrome treatment »

The FDA granted orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
10/16/18
10/16
10:02
10/16/18
10:02
General news
Housing Market Index data reported »

October Housing Market…

CVS

CVS Health

$73.02

-0.02 (-0.03%)

10:02
10/16/18
10/16
10:02
10/16/18
10:02
Hot Stocks
CVS Pharmacy completes rollout of time delay safes in Washington, DC locations »

CVS Pharmacy that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.